Polina Sonis
Tel Litwinsky, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Neurofilament Light Chain Measurements by Centaur and Simoa Systems in Human and Murine Samples.
Journal: The Israel Medical Association journal : IMAJ
Published: February 25, 2026
Machine learning-based prediction of disease progression in primary progressive multiple sclerosis.
Journal: Brain communications
Published: May 30, 2024
Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation.
Journal: Neurobiology of disease
Published: January 07, 2024
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab.
Journal: Multiple sclerosis and related disorders
Published: February 04, 2023
COVID-19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID-19 pediatric convalescents.
COVID-19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID-19 pediatric convalescents.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: May 30, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod.
Journal: Journal of neurology
Published: December 15, 2021
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose.
Journal: Journal of the neurological sciences
Published: November 08, 2021
SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: October 01, 2021
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study.
Journal: Journal of neuroimmunology
Published: August 31, 2021
Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
Journal: Therapeutic advances in neurological disorders
Published: June 09, 2021
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
Journal: Therapeutic advances in neurological disorders
Published: March 17, 2021
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: February 23, 2021
Last Updated: 09/26/2026